Custom Tracking Projects

See a Sample Tracking Report**

New Medicine offers tracking of oncology agents in development. A competitive landscape can be presented for any product in your current pipeline. Subscribing companies to nm|OK Custom Tracking Projects typically request monitoring for 10-20 separate drugs. Tracking reports are usually delivered in Microsoft Excel® Spreadsheet format. Separate worksheets can be created within the spreadsheet based on an internal product in development, clinical indication, phase, approval, etc.

• The Primary Tracking Sheet is designed to monitor a high priority set of agents. This sheet provides an overall analysis of individual drugs in development which are presented in greater detail on individual product records.
• Secondary Tracking Lists may cover agents in research, pre-clinical, and early clinical phase of development.
• A Product Record is designed to present a full detailed report on an agent presented in either the Primary or Secondary Tracking List. Any aspect of a drug can be requested for monitoring and presented on a Product Record in full detail.
• Any characteristic or reported aspect of a drug in development can be added or designed by a subscriber. Individual cells can be designated by a subscriber to highlight any important aspect of a novel drug.
• Any cancer indication of interest can be monitored. Lead indications represent highest advanced clinical phase.
• Combination trails are monitored and elaborated upon in greater detail in the Product Records.
• ASCO, EORTC, etc. reported clinical results are presented. All major publications of clinical efficacy are detailed with references.
• Entire side effect profiles may be included with severity and grade descriptions.

Please for details.